BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014
Ryogen LLC Awarded Two Patents Directed To Polynucleotide Sequences That Play Key Roles In Various Cancers 7/29/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses 7/28/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan 7/28/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Cellular Dynamics International Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples 7/10/2014
Alkermes plc (ALKS) Announces Notices of Allowance For U.S. Patents For Four CNS Pipeline Candidates 7/9/2014
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014
Aegis Therapeutics, LLC Awarded US Patent For Stable "Shirt-Pocket" Insulin Suitable For Metered Nasal Spray Or Injection 7/8/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
Sirnaomics Strengthens Its IP Position For Advancing The Company's Novel siRNA Therapeutics Programs 7/8/2014
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014
Seres Health Announces Allowance For Key Patent On The Use Of Synergistic Bacterial Compositions 7/7/2014
22nd Century Group, Inc. Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene 7/3/2014
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Broad FZD-Fc Composition-Of-Matter And Use Patent In U.S. 7/2/2014
Valensa Is Granted New Patents For "Worry Free" Chia-Based Ingredients 7/1/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014
Premier Biomedical Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia 6/30/2014
Actavis (ACT) Confirms Generic Zubsolv® Patent Challenge 6/30/2014
Mati Therapeutics Expands Patent Portfolio 6/30/2014
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014
Ryogen LLC Is Awarded Patent For Polynucleotides Related To Tumor-Suppressing Subtransferable Candidate 4 6/24/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent Office For Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-Cher2 6/23/2014
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014
TriLink BioTechnologies Awarded Patents For Novel Ligation Technology In US, Europe And New Zealand 6/19/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Actavis (ACT) Confirms District Court Ruling In Generic Exelon® Patch Patent Suit 6/19/2014
Drawbridge Pharmaceuticals Granted New Anaesthesia Patent For Phaxan™ In China 6/18/2014
Forest Laboratories, Inc. (FRX) Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® 6/18/2014
Patrys Limited (PAB.AX) Granted Third U.S. Patent For Lead Clinical Product PAT-SM6 6/18/2014
ProLynx Issues U.S. Patent Covering Controlled Release Drug Conjugates 6/18/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014
Essentialis Announces The Grant Of Its First Japanese Patent Which Provides Extensive Protection To DCCR In The Treatment Of Prader-Willi Syndrome 6/17/2014
ArmaGen Technologies, Inc. Receives Notice Of Allowance For U.S. Patent Covering Novel Investigational Therapy For Hunter Syndrome 6/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
The United States Patent Office Grants Neol Biosolutions The Patent For The Technology Microbioil-1® 6/12/2014
Spherix (SPEX) Commences Litigation Against Verizon For Patent Infringement 6/12/2014
Zealand Pharma  (ZEAL.CO)’s GLP-2 Analogue European Patent Rights Upheld By The European Patent Office Opposition Division 6/12/2014
Alnylam Pharmaceuticals (ALNY) Announces United States Patent And Trademark Office (USPTO) Issues Patent Covering Rnai Therapeutics For The Treatment Of Hepatitis B Virus (HBV) Infection 6/12/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
BioLineRx Ltd. Receives Notice Of Allowance For US Patent Covering Novel Treatment For Celiac Disease 6/11/2014
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014
iBio, Inc. (IBIO) Expands IP Protection Of Biotherapeutic Product For Treatment Of Fibrosis 6/10/2014
Titan Pharmaceuticals (TTP) Receives Notice Of Allowance For Patent Of Implantable Polymeric Device For Sustained Release Of Dopamine Agonists 6/10/2014
Palatin Technologies (PTN) Announces Notification Of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides 6/10/2014
Stemedica Cell Technologies, Inc. Earns U.S. Patent For Cellular Scaffold Enhanced By Stem Cell Factors 6/10/2014
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Xenetic Biosciences Strengthens Technology Patent Portfolio 6/9/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Patent Term Extension For Ferumoxytol In The U.S. 6/6/2014
Marina Biotech, Inc. (MRNA) Receives Decision To Grant Japanese Patent For Its SMARTICLES Nucleic Acid Delivery Technology 6/6/2014
Enzo Biochem (ENZ) Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy 6/6/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived From Viruses For Treating A Range Of Cancers 6/5/2014
iBio, Inc. (IBIO) European Patent On iBioModulator Technology Emerges From Opposition Period 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
Anavex Life Sciences Corp. (AVXL.OB) Awarded New U.S. Patent 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Mylan Inc. (MYL) Settles Patent Litigation Related To Celebrex® Capsules 6/2/2014
Actavis (ACT) Announces Nuvigil® Patent Challenge Settlement 6/2/2014
Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™ 5/28/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding 5/28/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 In Diabetic Nephropathy, A Progressive Kidney Disease 5/28/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Prima Biomed (PRR.AX)'s CVac Patent Application Receives U.S. Notice Of Allowance 5/27/2014
Hemispherx Biopharma (HEB) Receives New U.S. Composition Of Matter Patent Covering Ampligen® Formulations 5/27/2014
Batu Biologics Files Patent Covering Its Proprietary Cancer Vaccine Targeting The Tumor Endothelium: Vallovax 5/27/2014
Transposagen Biopharmaceuticals, Inc. Issued Key U.S. Patent Covering Rat Models Of Cancer 5/23/2014
Suven Life Sciences Ltd Product Patents In Australia, South Korea And China 5/19/2014
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product 5/19/2014
Neos Therapeutics Announces Issuance Of New Patent Covering Composition Of Matter For Company’s Novel ADHD Products 5/15/2014
BioLight Announces U.S. Patent Approval For Its Formulation Of Latanoprost In Its Proprietary Controlled Release Insert For The Treatment Of Glaucoma 5/14/2014
Appethyl's U.S. Patent, "Use Of Plant Cell Membrane For The Treatment Of Obesity" Issued To Greenleaf Medical AB 5/13/2014
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014
Batu Biologics Files Patent Covering New Use Of Approved Drug For Decreasing Cancer Immunotherapy Toxicity 5/12/2014
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Pivotal Therapeutics Inc. Announces Issuance Of U.S. Patent 8,715,648 For Its Unique 6:1 EPA:DHA Formulation 5/8/2014
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014
Discovery Laboratories (DSCO) Expands Exclusivity Portfolio With Three New U.S. Patents 5/7/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations And Combination Treatments 5/5/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
ADial Pharmaceuticals Announces Issuance Of First U.S. Patent 5/1/2014
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Trial Resulting In Exclusivity Through 2026 4/30/2014
KemPharm, Inc. Receives Notice Of Allowance For Novel Prodrug Of Hydromorphone 4/30/2014
BioAtla Receives Broad Patent Covering Conditionally Active Biologics 4/30/2014
Curis, Inc. (CRIS) Announces U.S. Patent Issuance Covering CUDC-907 Composition-Of-Matter 4/30/2014
Braasch Biotech Continues To Build Patent Portfolio With Acceptances In The European Union, Russia And Israel 4/28/2014
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent 4/24/2014
iBio, Inc. (IBIO) Receives Patent Allowance In China For Fusion Protein Compositions And Technology 4/24/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
U.S. District Court Finds In Favor Of Azbil BioVigilant, Inc. In Patent Litigation Dispute 4/24/2014
Epizyme (EPZM) Announces Notice Of Allowance For U.S. Patent Application Covering Methods Of Treatment For Cancers With EZH2 Inhibitors 4/24/2014
BaroFold, Inc. Awarded Patent For Using High Pressure To Improve The Safety Profile Of Biologic Drugs 4/23/2014
ProLynx Issues U.S. Patent Covering Controlled Drug Release From Dendrimers 4/23/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014
Skystar Bio-Pharmaceutical (CGPN) Provides Update To Its Patent Portfolio 4/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Settles Patent Litigation With Pfizer Inc. (PFE) On Celebrex® 4/17/2014
IntelGenx Corp. Announces Receipt Of An Additional U.S. Patent Allowance Related To Proprietary Technology 4/16/2014
Xeris Pharmaceuticals Receives U.S. Patent For Its Novel, Stable Non-Aqueous Glucagon Formulations 4/16/2014
Antares Pharma, Inc. (ATRS) Announces Additional Patent Coverage For OTREXUP 4/16/2014
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014
Alzheon Announces Notice Of Allowance For U.S. Patent For Its Lead Drug Candidate ALZ-801 In Clinical Development For Alzheimer’s Disease 4/15/2014
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014
Japan Patent Office Issues Advaxis, Inc. A Notice Of Allowance For Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology 4/14/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In Canada And Hong Kong 4/10/2014
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued An Additional Notice Of Allowance With Claims Covering RAYOS® (Prednisone) Delayed-Release Tablets 4/10/2014
BrainStorm Cell Therapeutics Inc. Granted Additional US Patent For Its Autologous Stem Cell Technology 4/10/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Hong Kong For Oral Administration Of Insulin 4/10/2014
American CryoStem Corporation And Rutgers University File Joint Patent On Adipose-Derived Stem Cell Platform Technology 4/10/2014
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014
Epizyme (EPZM) Granted Patent Covering Diagnosis And Treatment Of Cancers Associated With EZH2 Mutation 4/8/2014
USPTO Grants A New Inhaler Patent To Hovione 4/7/2014
Alnylam Pharmaceuticals (ALNY)’s McSwiggen Patent Upheld in European Opposition Proceedings 4/7/2014
United States PTO Rejects Teva's '808 Patent Reissue Application On Copaxone® For The Second Time 4/4/2014
AnaptysBio, Inc. Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology 4/3/2014
IntelliCell BioSciences (SVFC) Has Received Its Hong Kong Patent Application Notice For ULTRASONIC CAVITATION 4/2/2014
Mersana Therapeutics, Inc. Awarded Patent With Broad Coverage For Fleximer-ADC Platform Technology 4/2/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014
Eagle Pharmaceuticals (EGRX)’ Exclusive Licensor Granted U.S. Patent For Dantrolene In The Treatment Of Heat Stroke 4/1/2014
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent And Trademark Office For Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology 4/1/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent 3/31/2014
Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery 3/31/2014
iBio, Inc. (IBIO) Receives Patent Allowances For Pandemic Influenza Therapeutics 3/27/2014
ProLynx Issues U.S. Patent Covering Beta-Eliminative Linkers 3/26/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014
Iroko Pharmaceuticals Announces Key Patent Grant For ZORVOLEX™ 3/25/2014
BrainStorm Cell Therapeutics Inc. Granted Key US Patent For Its Autologous Stem Cell Technology 3/24/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Launches New Patent Pending Formulation Of Kerasal Nail In The U.S. 3/24/2014
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014
MultiCell Technologies Inc. (MCET.OB) Files U.S. And International Patent Applications For The Treatment Of Liver Cancer 3/21/2014
TapImmune Inc. (TPIV) Is Pleased To Announce The Filing Of New Intellectual Property Surrounding Its Novel And Proprietary Platform Expression System Polystart™ 3/20/2014
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014
Collegium Pharmaceutical, Inc. Announces Allowance Of New Claims Covering DETERx®, An Abuse-Deterrent, Extended-Release, Technology Platform 3/19/2014
Advaxis, Inc. Receives Patent In Japan For ADXS-HPV For The Treatment Of Cervical Cancer 3/18/2014
Idenix Pharmaceuticals, Inc. (IDIX) Files Patent Infringement Lawsuits Against Gilead Sciences, Inc. (GILD) In Europe 3/14/2014
BioLineRx Ltd. Announces Issuance Of United States Patent Covering Use Of BL-8040 In Immunotherapy 3/14/2014
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014
TNI BioTech Granted Additional Patent For Methods For Inducing Sustained Immune Response Of T-Cells 3/12/2014
XBiotech USA, Inc. Issued Patent For Antibody Therapy To Treat Chronic Sterile Inflammatory Diseases 3/12/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Trokendi XR™ 3/12/2014
Elite Pharmaceuticals, Inc. (ELI) Expands Abuse Deterrent Technology Patent Portfolio Internationally 3/10/2014
Ensysce Biosciences Inc. Receives Notice Of Allowance For U.S. Patent For Delivery Of siRNA 3/7/2014
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014
RXi Pharmaceuticals (RXII) Granted Key Patent Related To Self-Delivering Technology For The Treatment Of Fibrotic Disorders 3/5/2014
Braasch Biotech Bolsters Intellectual Property With Patent Acceptances In Australia And Japan 3/4/2014
Synageva BioPharma (GEVA) Issued U.S. Patent For Treatment Of LAL Deficiency 3/4/2014
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014
Actavis (ACT) Confirms Generic Colcrys® Patent Challenge 2/28/2014
Galena Biopharma  (GALE) Bolsters Neuvax™ (Nelipepimut-S) Intellectual Property With Patent Acceptance In Australia 2/28/2014
Immunomedics, Inc. (IMMU) Extends Patent Life On Therapeutic Antibodies 2/27/2014
Meditope Biosciences Announces Issuance of New Patent 2/26/2014
Theranostics Health Announces Issuance Of U.S. Patent 8,628,931 B2: mTOR Pathway Theranostic 2/26/2014
Galectin Therapeutics Secures U.S. Patent For Its Proprietary Galectin Inhibitor GR-MD-02 In Fatty Liver Disease 2/26/2014
IntelGenx Corp. Announces Receipt Of Two Additional U.S. Patent Allowances Related To Proprietary Technology 2/26/2014
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treatment Of Dry Eye Syndrome 2/24/2014
Rockwell Medical (RMTI) Receives Japanese Patent Issuance For Triferic™ GMP Formulation 2/21/2014